CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,092,966 | -9.7% | 37,100 | 0.0% | 0.02% | +5.9% |
| Q2 2023 | $1,210,202 | -36.5% | 37,100 | -31.5% | 0.02% | -39.3% |
| Q1 2023 | $1,907,298 | -23.2% | 54,200 | 0.0% | 0.03% | -15.2% |
| Q4 2022 | $2,483,444 | -28.0% | 54,200 | -23.9% | 0.03% | -34.0% |
| Q3 2022 | $3,450,000 | +32.2% | 71,200 | +7.2% | 0.05% | +35.1% |
| Q2 2022 | $2,609,000 | +2.7% | 66,400 | -3.8% | 0.04% | +27.6% |
| Q1 2022 | $2,540,000 | – | 69,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |